- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
- 10-K Annual report
- 10.3 Amendment to Employment Agreement with Doug Baker, Dated March 10, 2020
- 10.4 Amendment to Employment Agreement with William Febbo, Dated March, 10, 2020
- 10.5 Amendment to Employment Agreement with Stephen Silvestro, Dated March, 10, 2020
- 10.6 Amendment to Employment Agreement with Miriam Paramore, Dated March, 10, 2020
- 21.1 List of Subsidiaries
- 23.1 Consent of Marcum LLP
- 31.1 Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13A-14(A)/15D-14(A), As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13A-14(A)/15D-14(A), As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Exhibit 10.4
Employment Agreement Addendum I
Addendum to agreement dated September 10, 2018
This first addendum to the employment agreement (the “Addendum”) is made this 10th day of March 2020, by and between OptimizeRx, Corporation (the “Company”), a Nevada Company, and William Febbo (the “Executive”).
Base Salary: The Executive will receive a base salary at the annualized rate of $350,000.00 (“Base Salary”), for 2020 and $400,000.00 for 2021 calendar year, which will be paid in accordance with normal Company payroll practices and subject to the usual and applicable required withholding(s).
Effective Date: January 1, 2020 & January 1, 2021
Acknowledgment:
Except as expressly set forth herein, all other terms of the Agreement remain in full force and effect.
| OptimizeRx, Corporation | William Febbo | |||
| By: | Douglas P. Baker | By: | William Febbo | |
| Its: | Chief Financial Officer | Date: | March 10, 2020 | |
| Date: | March 10, 2020 | |||